AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16719653 — intervention group
Group type: EXPERIMENTAL
Intervention: Commonly used measures of judgment accuracy (absolute and relative accuracy)
Number of subjects: 0
Study 15532005 — intervention group
Group type: EXPERIMENTAL
Intervention: Music (trance, tempo = 142 beats/min, volume = 87 dB)
Number of subjects: 16
Study 15532005 — intervention group
Group type: COMPARATOR
Intervention: No music (control)
Number of subjects: 16
Study 15532005 — intervention group
Group type: EXPERIMENTAL
Intervention: Music (trance)
Number of subjects: 16
Study 11286443 — intervention group
Group type: EXPERIMENTAL
Intervention: Various treatments for cluster headaches; specific interventions not detailed; no dosage or duration mentioned.
Number of subjects: 0
Study 9258477 — intervention group
Group type: EXPERIMENTAL
Intervention: Deployment time of 5 min
Number of subjects: 140
Study 9258477 — intervention group
Group type: COMPARATOR
Intervention: Deployment time of 30 min
Number of subjects: 140
Study 8280555 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 cm H2O CPAP with air
Number of subjects: 61
Study 8280555 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 cm H2O CPAP with 100% oxygen
Number of subjects: 61
Study 8280555 — intervention group
Group type: COMPARATOR
Intervention: No CPAP
Number of subjects: 61
Study 3816081 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol consumption
Number of subjects: 8
Study 29766701 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical daily application of a lotion containing N1‐methylspermidine and Sandalore
Number of subjects: 60
Study 27090975 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Surveillance (AS) with prostate-specific antigen tests every 3-12 months, rebiopsies in cases of clinical progression, and every 2-3 years in men with stable disease.
Number of subjects: 474
Study 27090975 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Surveillance (AS)
Number of subjects: 474
Study 24281004 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-escalated weekly paclitaxel (80-120 mg/m²)
Number of subjects: 90
Study 24281004 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose weekly paclitaxel (80 mg/m²)
Number of subjects: 90
Study 22322126 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% chlorhexidine (CHX) solution applied to the umbilical cord at birth and once daily for up to 14 days along with soap and educational messages promoting handwashing.
Number of subjects: 9741
Study 22322126 — intervention group
Group type: EXPERIMENTAL
Intervention: Handwashing promotion only.
Number of subjects: 9741
Study 22322126 — intervention group
Group type: COMPARATOR
Intervention: Standard dry cord care (control group).
Number of subjects: 9741
Study 20385495 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole (B+C; N=65)
Number of subjects: 120
Study 20385495 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (A+D; N=55)
Number of subjects: 120
Study 18939344 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Cyclosporin A (Restasis) with intensive prednisolone acetate
Number of subjects: 108
Study 18939344 — intervention group
Group type: COMPARATOR
Intervention: Placebo with intensive prednisolone acetate
Number of subjects: 108
Study 16234072 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction elastic band ligator
Number of subjects: 100
Study 16234072 — intervention group
Group type: COMPARATOR
Intervention: Forceps ligator
Number of subjects: 100
Study 12110996 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg pyridostigmine bromide (PB)
Number of subjects: 67
Study 12110996 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg pyridostigmine bromide (PB)
Number of subjects: 67
Study 12110996 — intervention group
Group type: COMPARATOR
Intervention: pyridostigmine bromide (PB)
Number of subjects: 67
Study 10640206 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary stenting (group II)
Number of subjects: 163
Study 10640206 — intervention group
Group type: COMPARATOR
Intervention: Primary angioplasty using only balloon (group I)
Number of subjects: 163
Study 7710451 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional statistical methods (t-test, mean values, boxplot)
Number of subjects: 0
Study 7710451 — intervention group
Group type: EXPERIMENTAL
Intervention: Wilcoxon-Mann-Whitney test
Number of subjects: 0
Study 2162258 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 97
Study 2162258 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 97
Study 385400 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 86
Study 385400 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 31899792 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric atrophy (defined as a serum level of pepsinogen I <55 μg/L)
Number of subjects: 1210
Study 31899792 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric atrophy and poor oral health interaction
Number of subjects: 1210
Study 31859347 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness
Number of subjects: 78
Study 31859347 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction
Number of subjects: 78
Study 31859347 — intervention group
Group type: COMPARATOR
Intervention: Associative focus
Number of subjects: 78
Study 29781525 — intervention group
Group type: EXPERIMENTAL
Intervention: Health post intervention
Number of subjects: 282
Study 29781525 — intervention group
Group type: EXPERIMENTAL
Intervention: Health center intervention
Number of subjects: 282
Study 29781525 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 282
Study 29781525 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall intervention
Number of subjects: 282
Study 26944326 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex (4 mg/kg)
Number of subjects: 60
Study 26944326 — intervention group
Group type: COMPARATOR
Intervention: Neostigmine (50 μg/kg) plus atropine (15 μg/kg)
Number of subjects: 60
Study 23236208 — intervention group
Group type: EXPERIMENTAL
Intervention: Music training
Number of subjects: 0
Study 23236208 — intervention group
Group type: COMPARATOR
Intervention: Painting training
Number of subjects: 0
Study 22639053 — intervention group
Group type: COMPARATOR
Intervention: Fixed-schedule induction therapy
Number of subjects: 242
Study 22639053 — intervention group
Group type: COMPARATOR
Intervention: Individualized induction therapy
Number of subjects: 242
Study 22639053 — intervention group
Group type: EXPERIMENTAL
Intervention: Ubenimex
Number of subjects: 242
Study 22639053 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender (female patients)
Number of subjects: 242
Study 20029377 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 g fructose daily for 2 weeks
Number of subjects: 74
Study 20029377 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 74
Study 19029205 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (cholesterol-lowering drug)
Number of subjects: 0
Study 19029205 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 0
Study 16155766 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic colorectal resection
Number of subjects: 30
Study 16155766 — intervention group
Group type: COMPARATOR
Intervention: Conventional colorectal resection
Number of subjects: 30
Study 12211225 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetrorelix acetate (CET/glu, dose: 10 mg peptide base)
Number of subjects: 36
Study 12211225 — intervention group
Group type: COMPARATOR
Intervention: Cetrorelix acetate (CET/wat, dose: 10 mg peptide base)
Number of subjects: 36
Study 12211225 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetrorelix acetate (CET/glu, dose: 5 mg peptide base)
Number of subjects: 36
Study 10768735 — intervention group
Group type: EXPERIMENTAL
Intervention: Zafirlukast tablets (Accolate) 20 mg b.i.d.
Number of subjects: 132
Study 10768735 — intervention group
Group type: COMPARATOR
Intervention: Inhaled beclomethasone dipropionate (BDP) 100 or 200 microg b.i.d.
Number of subjects: 132
Study 10768735 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 132
Study 10768735 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaler technique assessment
Number of subjects: 132
Study 9041488 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal invitation letter with a set time of appointment
Number of subjects: 5000
Study 9041488 — intervention group
Group type: COMPARATOR
Intervention: Questionnaire and instructions for self-examination of the skin
Number of subjects: 5000
Study 9041488 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses' judgment of skin lesions
Number of subjects: 5000
Study 9041488 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctors' judgment of skin lesions
Number of subjects: 5000
Study 9041488 — intervention group
Group type: COMPARATOR
Intervention: Detection of malignant melanomas
Number of subjects: 5000
Study 9041488 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses' screening competence
Number of subjects: 5000
Study 1354618 — intervention group
Group type: EXPERIMENTAL
Intervention: Bunazosin 2.0 mg
Number of subjects: 7
Study 1354618 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 1354618 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg
Number of subjects: 7
Study 6084460 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron prophylaxis
Number of subjects: 0
Study 6084460 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 31839169 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen plus ovarian function suppression (T + OFS)
Number of subjects: 0
Study 31839169 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane plus ovarian function suppression (E + OFS)
Number of subjects: 0
Study 31839169 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (T)
Number of subjects: 0
Study 30119148 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil–propofol (RP group, n = 40)
Number of subjects: 83
Study 30119148 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil–propofol (SP group, n = 43)
Number of subjects: 83
Study 30119148 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil–propofol (RP group)
Number of subjects: 83
Study 30119148 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil–propofol (SP group)
Number of subjects: 83
Study 24680105 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol plus chlorhexidine
Number of subjects: 80
Study 24680105 — intervention group
Group type: COMPARATOR
Intervention: Alcohol alone
Number of subjects: 80
Study 22651373 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg/day
Number of subjects: 182
Study 22651373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study 20536430 — intervention group
Group type: EXPERIMENTAL
Intervention: Ready for Child programme (9 hours of antenatal training)
Number of subjects: 1193
Study 18538469 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix 200 mg initial dose
Number of subjects: 187
Study 18538469 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix 240 mg initial dose
Number of subjects: 187
Study 18538469 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix 160 mg monthly maintenance dose
Number of subjects: 187
Study 18538469 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix (all dosages)
Number of subjects: 187
Study 18538469 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix treatment
Number of subjects: 187
Study 15854217 — intervention group
Group type: EXPERIMENTAL
Intervention: on-line hemodiafiltration (HDF)
Number of subjects: 27
Study 15854217 — intervention group
Group type: COMPARATOR
Intervention: low-flux hemodialysis (HD)
Number of subjects: 27
Study 12442064 — intervention group
Group type: COMPARATOR
Intervention: Insulin twice daily (premixed combination of regular human and NPH insulin)
Number of subjects: 16
Study 12442064 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedtime NPH insulin combined with daytime sulphonylurea (combination group)
Number of subjects: 16
Study 10616949 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological therapy (individual cognitive behavioural therapy and applied relaxation)
Number of subjects: 404
Study 10616949 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological therapy (aggregate data across types of treatment)
Number of subjects: 404
Study 10616949 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological therapy (12 of the 20 treatment conditions)
Number of subjects: 404
Study 7853954 — intervention group
Group type: EXPERIMENTAL
Intervention: Dantrolene (3 days treatment)
Number of subjects: 0
Study 7853954 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified treatment)
Number of subjects: 0
Study 7853954 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with exertional rhabdomyolysis (baseline)
Number of subjects: 0
Study 2006594 — intervention group
Group type: COMPARATOR
Intervention: Saline + Propofol 2.5 mg.kg‐1
Number of subjects: 59
Study 2006594 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 20 micrograms.kg‐1 + Propofol 2.5 mg.kg‐1
Number of subjects: 59
Study 2006594 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 30 micrograms.kg‐1 + Propofol 2.5 mg.kg‐1
Number of subjects: 59
Study 2006594 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 30 micrograms.kg‐1 + Propofol 2.5 mg.kg‐1 (Control for Pain)
Number of subjects: 59
Study 6844366 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol (10 mg)/Hydrochlorothiazide (25 mg)/Amiloride (2.5 mg) preparation
Number of subjects: 558
Study 6844366 — intervention group
Group type: COMPARATOR
Intervention: Full explanation for the change in therapy
Number of subjects: 558
Study 6844366 — intervention group
Group type: COMPARATOR
Intervention: Simple notification of treatment change
Number of subjects: 558
Study 31655586 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 55
Study 31655586 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 55
Study 30443679 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha (IFN‐α) administered subcutaneously at a dosage of 15,000 Units for three consecutive days following myocardial infarction in a rat model
Number of subjects: 51
Study 30443679 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of type I interferon (IFN) signalling in human monocytes
Number of subjects: 51
Study 27374272 — intervention group
Group type: EXPERIMENTAL
Intervention: Elental
Number of subjects: 33
Study 27374272 — intervention group
Group type: COMPARATOR
Intervention: Azulene
Number of subjects: 33
Study 27374272 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 33
Study 25122975 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinbrush Truly Radiant Deep Clean (TRDC)
Number of subjects: 65
Study 25122975 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinbrush Truly Radiant Extra Whitening (TREW)
Number of subjects: 65
Study 25122975 — intervention group
Group type: COMPARATOR
Intervention: Manual Toothbrush (MT)
Number of subjects: 65
Study 25122975 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinbrush Truly Radiant Deep Clean (TRDC) and Spinbrush Truly Radiant Extra Whitening (TREW)
Number of subjects: 65
Study 18198195 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept treatment
Number of subjects: 0
Study 18198195 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study 15293420 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive system applied to human enamel (H-E)
Number of subjects: 30
Study 15293420 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive system applied to bovine enamel (B-E)
Number of subjects: 30
Study 15293420 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive system applied to porcine enamel (P-E)
Number of subjects: 30
Study 15293420 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive system applied to human dentin (H-D)
Number of subjects: 30
Study 15293420 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive system applied to bovine dentin (B-D)
Number of subjects: 30
Study 15293420 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive system applied to porcine dentin (P-D)
Number of subjects: 30
Study 15293420 — intervention group
Group type: COMPARATOR
Intervention: Comparison of bond strengths between human, bovine, and porcine teeth
Number of subjects: 30
Study 11093698 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen administration during walks
Number of subjects: 31
Study 11093698 — intervention group
Group type: COMPARATOR
Intervention: Compressed air (control)
Number of subjects: 31
Study 9351876 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoradiometric assay (I‐BALP)
Number of subjects: 198
Study 9351876 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrophoretic techniques (E‐BALP)
Number of subjects: 198
Study 9351876 — intervention group
Group type: EXPERIMENTAL
Intervention: Total alkaline phosphatase (TALP)
Number of subjects: 198
Study 9351876 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate therapy (60 mg every 3 weeks, administered 4 times)
Number of subjects: 198
Study 9351876 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone gla protein (BGP)
Number of subjects: 198
Study 9351876 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboxyterminal propeptide of type I procollagen (PICP)
Number of subjects: 198
Study 8214731 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine 2 mg/fentanyl 50 micrograms
Number of subjects: 120
Study 8214731 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine 2 mg/fentanyl 100 micrograms
Number of subjects: 120
Study 8214731 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine 4 mg/fentanyl 50 micrograms
Number of subjects: 120
Study 8214731 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine 4 mg/fentanyl 100 micrograms
Number of subjects: 120
Study 2890808 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant alpha-interferon
Number of subjects: 0
Study 31414957 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute xenon inhalation (30% FiXe for 20 min, 50% FiXe for 5 min, 70% FiXe for 2 min)
Number of subjects: 27
Study 31414957 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic xenon inhalation (70% FiXe for 2 min on 7 consecutive days)
Number of subjects: 27
Study 31414957 — intervention group
Group type: COMPARATOR
Intervention: 4 wk of xenon inhalation (Phase II)
Number of subjects: 27
Study 28131837 — intervention group
Group type: EXPERIMENTAL
Intervention: Isomerized hop extract (IHE)
Number of subjects: 23
Study 28131837 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 27465523 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain stimulation
Number of subjects: 18
Study 27465523 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain stimulation with ICU sound
Number of subjects: 18
Study 27465523 — intervention group
Group type: COMPARATOR
Intervention: Negative emotions
Number of subjects: 18
Study 25325609 — intervention group
Group type: EXPERIMENTAL
Intervention: Armodafinil 250 mg/day
Number of subjects: 117
Study 25325609 — intervention group
Group type: EXPERIMENTAL
Intervention: Armodafinil 150 mg/day
Number of subjects: 117
Study 25325609 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 25325609 — intervention group
Group type: EXPERIMENTAL
Intervention: Armodafinil (50, 150, or 250 mg/day)
Number of subjects: 117
Study 25325609 — intervention group
Group type: EXPERIMENTAL
Intervention: Armodafinil
Number of subjects: 117
Study 25325609 — intervention group
Group type: EXPERIMENTAL
Intervention: Armodafinil (open-label extension)
Number of subjects: 117
Study 22772666 — intervention group
Group type: EXPERIMENTAL
Intervention: Cued category fluency task
Number of subjects: 86
Study 22772666 — intervention group
Group type: COMPARATOR
Intervention: Uncued category fluency task
Number of subjects: 86
Study 19606509 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture stimulation (AS) for 20 min at Baihui (GV 20) and 4 spirit acupoints
Number of subjects: 30
Study 19606509 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture stimulation (AS)
Number of subjects: 30
Study 19606509 — intervention group
Group type: COMPARATOR
Intervention: Control group (no manual twisting of needles, no qi)
Number of subjects: 30
Study 17311944 — intervention group
Group type: EXPERIMENTAL
Intervention: beta-glucan muesli
Number of subjects: 40
Study 17311944 — intervention group
Group type: EXPERIMENTAL
Intervention: combination muesli
Number of subjects: 40
Study 17311944 — intervention group
Group type: EXPERIMENTAL
Intervention: plant stanols
Number of subjects: 40
Study 14967379 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg daily)
Number of subjects: 50
Study 14967379 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 11527457 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilization with movement (MWM) applied to the elbow
Number of subjects: 23
Study 9476035 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 16 mg once daily
Number of subjects: 232
Study 7946164 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nicardipine
Number of subjects: 121
Study 7946164 — intervention group
Group type: COMPARATOR
Intervention: Intravenous nitroprusside (SNP)
Number of subjects: 121
Study 3284065 — intervention group
Group type: EXPERIMENTAL
Intervention: Aza (2.1 mg/kg/d) plus MP (3.6 mg/kg/d tapered to 0.5 mg/kg/d by day 15)
Number of subjects: 96
Study 3284065 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA (10 mg/kg/d tapered to 8 mg/kg/d by day 28)
Number of subjects: 96
Study 3284065 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA (10 mg/kg/d tapered to 8 mg/kg/d by day 28) plus MP (3.6 mg/kg/d tapered to 0 mg/kg/d by day 9)
Number of subjects: 96
Study 30099395 — intervention group
Group type: EXPERIMENTAL
Intervention: Morita Therapy plus treatment as usual (TAU)
Number of subjects: 68
Study 30099395 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 68
Study 27585724 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 0
Study 27585724 — intervention group
Group type: COMPARATOR
Intervention: Local Anesthesia
Number of subjects: 0
Study 24898858 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (brief, clinic-based, single-session programme)
Number of subjects: 311